Spyre Therapeutics, Inc. SYRE Issuances of common stock from employee benefit plans receivable
Issuances of common stock from employee benefit plans receivable at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConversionOfStockAmountIssued1.
The official record: Spyre Therapeutics, Inc.’s 10-K/A, filed November 18, 2024, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s issuances of common stock from employee benefit plans receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s issuances of common stock from employee benefit plans receivable?
- Spyre Therapeutics, Inc. (SYRE) reported issuances of common stock from employee benefit plans receivable of $50.54M in Q4 2023.